查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585675

果凍市場：按產品、來源、應用和最終用戶 - 2025-2030 年全球預測

Biosurgery Market by Product (Adhesion Barriers, Bone Graft Attachments, Hemostatic Agents), Source (Biologics Products, Synthetic Products), Application, End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年果凍市場價值為151.3億美元，預計到2024年將達到163.5億美元，複合年成長率為8.17%，到2030年將達到262.2億美元。

果凍市場專注於有助於止血、封閉和組織修復的生物衍生外科產品的開發和應用。該領域對於改善手術結果、降低手術風險和促進康復至關重要。在人口老化、外科手術增加和技術進步的推動下，該市場有望成長，但面臨高成本和嚴格監管等挑戰。果凍可應用於各種外科手術，包括整形外科、心血管外科和神經外科，最終使用者是醫院、診所和門診手術中心。成長主要歸因於對微創手術的日益關注、新興市場的擴張以及全球醫療基礎設施的改善。商業機會在於開發下一代、具成本效益和有效的產品，這些產品反映了生物相容性材料和再生醫學的進步。然而，市場成長受到定價壓力、報銷問題和高資本投資要求的阻礙。一個顯著的限制是，由於意識和基礎設施不足，在低度開發地區採用緩慢。新的商機包括組織支架的創新、生物活性創傷護理產品以及利用生物技術進步的個人化醫療方法的開發。公司可以透過投資加強生醫材料的研發並利用與研究機構的策略聯盟來加速技術進步，從而利用這些前景。此外，在醫療支出不斷增加的新興國家擴大銷售網路也可能是可行的成長策略。促進與醫療保健提供者的夥伴關係以及提高產品的可用性和可負擔性將發揮關鍵作用。保持適應不斷變化的法規並專注永續實踐將進一步確保競爭格局的彈性。畢竟，市場動態是動態和競爭的，創新和監管敏捷性是持續成功的關鍵。

主要市場統計
基準年[2023] 151.3億美元
預測年份 [2024] 163.5億美元
預測年份 [2030] 262.2億美元
複合年成長率（%） 8.17%

市場動態：揭示快速發展的果凍市場的關鍵市場洞察

供需的動態交互作用正在改變果凍市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 老年人口增加及微創手術增加
    • 患者對有效控制出血的需求日益增加
    • 政府加大對果凍的投資
  • 市場限制因素
    • 對果凍高成本的擔憂
  • 市場機會
    • 介紹利用尖端技術的果凍產品
    • 醫療旅遊的潛在發展和對先進生物材料日益成長的需求
  • 市場挑戰
    • 嚴格的法律規範和缺乏臨床專業知識

波特的五力：駕馭果凍市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解果凍市場的外部影響

外部宏觀環境因素在塑造果凍市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解果凍市場的競爭狀況

對果凍市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣果凍市場供應商績效評估

FPNV定位矩陣是評估果凍市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了果凍市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，果凍市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化的加劇和微創手術的增加
      • 對有效患者失血管理的需求增加
      • 政府加大對果凍的投資
    • 抑制因素
      • 對果凍高成本的擔憂
    • 機會
      • 介紹先進的、技術主導的果凍產品
      • 醫療旅遊的潛在發展和對先進生物材料不斷成長的需求
    • 任務
      • 嚴格的法規結構和缺乏臨床專業知識
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章果凍市場：依產品

  • 防沾黏屏障
  • 骨移植附件
  • 止血劑
  • 軟組織附著
  • 手術密封劑

第7章果凍市場：依來源分類

  • 生技藥品
  • 合成產品

第8章果凍市場：依應用分類

  • 心血管外科
  • 一般外科
  • 婦科手術
  • 神經外科
  • 整形外科
  • 胸腔外科
  • 泌尿系統

第9章果凍市場：依最終用戶分類

  • 診所
  • 醫院

第10章美洲果凍市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太果凍市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的果凍市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aroa Biosurgery Limited
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • Boston Scientific Corporation
  • Cabaletta Bio, Inc.
  • CSL Limited
  • Getinge AB
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services Inc.
  • Kuros Bioscience AG
  • Medtronic PLC
  • Ocular Therapeutix, Inc.
  • Orthofix Medical, Inc.
  • Pfizer Inc.
  • RTI Surgical, Inc.
  • Samyang Holdings Corporation
  • Sanofi SA
  • Smith & Nephew plc
  • Stryker Corporation
  • Tissue Regenix Ltd
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-AD36CD8982F7

The Biosurgery Market was valued at USD 15.13 billion in 2023, expected to reach USD 16.35 billion in 2024, and is projected to grow at a CAGR of 8.17%, to USD 26.22 billion by 2030.

The biosurgery market focuses on the development and application of biologically-originated surgical products, aiding in hemostasis, sealing, and tissue repair. This segment is critical for enhancing surgical outcomes, reducing operative risks, and accelerating recovery. Driven by an aging population, increasing surgical procedures, and technological advancements, the market is poised for growth, yet it faces challenges such as high costs and stringent regulatory scrutiny. Biosurgery finds applications in various surgeries, including orthopedic, cardiovascular, and neurosurgeries, with end-users being hospitals, clinics, and ambulatory surgical centers. Growth is predominantly fueled by an increasing focus on minimally invasive procedures, expansion in emerging markets, and improved healthcare infrastructure globally. Opportunities lie in the development of cost-effective and effective next-generation products, reflecting advances in biocompatible materials and regenerative medicine. However, market growth is hampered by pricing pressures, reimbursement issues, and a high capital investment requirement. A noteworthy limitation is the slow adoption in underdeveloped regions due to inadequate awareness and infrastructure. Emerging opportunities include innovations in tissue scaffolding, bioactive wound care products, and development of personalized medicine approaches leveraging biotechnological advancements. Companies can capitalize on these prospects by investing in R&D for enhanced biomaterials and leveraging strategic collaborations with research institutes to foster technological advancements. Additionally, expanding distribution networks in emerging economies where healthcare expenditure is rising can be a viable growth strategy. Fostering partnerships with healthcare providers to enhance product accessibility and affordability will play a crucial role. Staying adaptive to changing regulations and focusing on sustainable practices may further ensure resilience in a competitive landscape. Ultimately, the biosurgery market's nature is dynamic and highly competitive, with innovation and regulatory agility being keys to sustained success.

KEY MARKET STATISTICS
Base Year [2023] USD 15.13 billion
Estimated Year [2024] USD 16.35 billion
Forecast Year [2030] USD 26.22 billion
CAGR (%) 8.17%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biosurgery Market

The Biosurgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population and increase in the volume of minimal-invasive surgeries
    • Growing need for effective blood loss management in patients
    • Increase in investments by the government in the biosurgery
  • Market Restraints
    • Concern associated with high cost of biosurgery
  • Market Opportunities
    • Introduction of advanced and tech-driven biosurgery products
    • Potential development of medical tourism and rise in need for advanced bio materials
  • Market Challenges
    • Stringent regulatory framework and dearth of clinical expertise

Porter's Five Forces: A Strategic Tool for Navigating the Biosurgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biosurgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biosurgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biosurgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biosurgery Market

A detailed market share analysis in the Biosurgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biosurgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biosurgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biosurgery Market

A strategic analysis of the Biosurgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biosurgery Market, highlighting leading vendors and their innovative profiles. These include Aroa Biosurgery Limited, Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson, and Company, Boston Scientific Corporation, Cabaletta Bio, Inc., CSL Limited, Getinge AB, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Kuros Bioscience AG, Medtronic PLC, Ocular Therapeutix, Inc., Orthofix Medical, Inc., Pfizer Inc., RTI Surgical, Inc., Samyang Holdings Corporation, Sanofi SA, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Ltd, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Biosurgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Adhesion Barriers, Bone Graft Attachments, Hemostatic Agents, Soft Tissue Attachments, and Surgical Sealants.
  • Based on Source, market is studied across Biologics Products and Synthetic Products.
  • Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Gynecology Surgery, Neurological Surgery, Orthopedic Surgery, Thoracic Surgery, and Urology Surgery.
  • Based on End-Users, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and increase in the volume of minimal-invasive surgeries
      • 5.1.1.2. Growing need for effective blood loss management in patients
      • 5.1.1.3. Increase in investments by the government in the biosurgery
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with high cost of biosurgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced and tech-driven biosurgery products
      • 5.1.3.2. Potential development of medical tourism and rise in need for advanced bio materials
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework and dearth of clinical expertise
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biosurgery Market, by Product

  • 6.1. Introduction
  • 6.2. Adhesion Barriers
  • 6.3. Bone Graft Attachments
  • 6.4. Hemostatic Agents
  • 6.5. Soft Tissue Attachments
  • 6.6. Surgical Sealants

7. Biosurgery Market, by Source

  • 7.1. Introduction
  • 7.2. Biologics Products
  • 7.3. Synthetic Products

8. Biosurgery Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Gynecology Surgery
  • 8.5. Neurological Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Thoracic Surgery
  • 8.8. Urology Surgery

9. Biosurgery Market, by End-Users

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Hospitals

10. Americas Biosurgery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biosurgery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biosurgery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aroa Biosurgery Limited
  • 2. Artivion, Inc.
  • 3. B. Braun Melsungen AG
  • 4. Baxter International Inc.
  • 5. Becton, Dickinson, and Company
  • 6. Boston Scientific Corporation
  • 7. Cabaletta Bio, Inc.
  • 8. CSL Limited
  • 9. Getinge AB
  • 10. Hemostasis, LLC
  • 11. Integra LifeSciences Corporation
  • 12. Johnson & Johnson Services Inc.
  • 13. Kuros Bioscience AG
  • 14. Medtronic PLC
  • 15. Ocular Therapeutix, Inc.
  • 16. Orthofix Medical, Inc.
  • 17. Pfizer Inc.
  • 18. RTI Surgical, Inc.
  • 19. Samyang Holdings Corporation
  • 20. Sanofi SA
  • 21. Smith & Nephew plc
  • 22. Stryker Corporation
  • 23. Tissue Regenix Ltd
  • 24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOSURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. BIOSURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOSURGERY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOSURGERY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOSURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOSURGERY MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOSURGERY MARKET SIZE, BY ADHESION BARRIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOSURGERY MARKET SIZE, BY BONE GRAFT ATTACHMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOSURGERY MARKET SIZE, BY SOFT TISSUE ATTACHMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOSURGERY MARKET SIZE, BY BIOLOGICS PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOSURGERY MARKET SIZE, BY GYNECOLOGY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOSURGERY MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOSURGERY MARKET SIZE, BY THORACIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOSURGERY MARKET SIZE, BY UROLOGY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOSURGERY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 195. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2023